SwePub
Sök i LIBRIS databas

  Extended search

onr:"swepub:oai:gup.ub.gu.se/267530"
 

Search: onr:"swepub:oai:gup.ub.gu.se/267530" > Growth Hormone Impr...

  • 1 of 1
  • Previous record
  • Next record
  •    To hitlist

Growth Hormone Improves Cognitive Function After Experimental Stroke

Ong, L. K. (author)
Chow, W. Z. (author)
Tebay, C. (author)
show more...
Kluge, M. (author)
Pietrogrande, G. (author)
Zalewska, K. (author)
Crock, P. (author)
Åberg, N David, 1970 (author)
Gothenburg University,Göteborgs universitet,Institutionen för medicin,Institute of Medicine
Bivard, A. (author)
Johnson, S. J. (author)
Walker, F. R. (author)
Nilsson, M. (author)
Isgaard, J. (author)
show less...
 (creator_code:org_t)
Ovid Technologies (Wolters Kluwer Health), 2018
2018
English.
In: Stroke. - : Ovid Technologies (Wolters Kluwer Health). - 0039-2499 .- 1524-4628. ; 49:5, s. 1257-1266
  • Journal article (peer-reviewed)
Abstract Subject headings
Close  
  • Background and Purpose-Cognitive impairment is a common outcome for stroke survivors. Growth hormone (GH) could represent a potential therapeutic option as this peptide hormone has been shown to improve cognition in various clinical conditions. In this study, we evaluated the effects of peripheral administration of GH at 48 hours poststroke for 28 days on cognitive function and the underlying mechanisms. Methods-Experimental stroke was induced by photothrombotic occlusion in young adult mice. We assessed the associative memory cognitive domain using mouse touchscreen platform for paired-associate learning task. We also evaluated neural tissue loss, neurotrophic factors, and markers of neuroplasticity and cerebrovascular remodeling using biochemical and histology analyses. Results-Our results show that GH-treated stroked mice made a significant improvement on the paired-associate learning task relative to non-GH-treated mice at the end of the study. Furthermore, we observed reduction of neural tissue loss in GH-treated stroked mice. We identified that GH treatment resulted in significantly higher levels of neurotrophic factors (IGF-1 [insulin-like growth factor-1] and VEGF [vascular endothelial growth factor]) in both the circulatory and peri-infarct regions. GH treatment in stroked mice not only promoted protein levels and density of presynaptic marker (SYN-1 [synapsin-1]) and marker of myelination (MBP [myelin basic protein]) but also increased the density and area coverage of 2 major vasculature markers (CD31 and collagen-IV), within the peri-infarct region. Conclusions-These findings provide compelling preclinical evidence for the usage of GH as a potential therapeutic tool in the recovery phase of patients after stroke. Visual Overview-An online visual overview is available for this article.

Subject headings

MEDICIN OCH HÄLSOVETENSKAP  -- Klinisk medicin -- Kardiologi (hsv//swe)
MEDICAL AND HEALTH SCIENCES  -- Clinical Medicine -- Cardiac and Cardiovascular Systems (hsv//eng)
MEDICIN OCH HÄLSOVETENSKAP  -- Medicinska och farmaceutiska grundvetenskaper -- Neurovetenskaper (hsv//swe)
MEDICAL AND HEALTH SCIENCES  -- Basic Medicine -- Neurosciences (hsv//eng)

Keyword

cognition
growth hormone
insulin-like growth factor-1
neuronal plasticity
stroke
vascular
traumatic brain-injury
stress-induced disruption
focal
cerebral-ischemia
photothrombotic stroke
secondary neurodegeneration
replacement therapy
gh replacement
mice
performance
poststroke
Neurosciences & Neurology
Cardiovascular System & Cardiology

Publication and Content Type

ref (subject category)
art (subject category)

Find in a library

  • Stroke (Search for host publication in LIBRIS)

To the university's database

  • 1 of 1
  • Previous record
  • Next record
  •    To hitlist

Kungliga biblioteket hanterar dina personuppgifter i enlighet med EU:s dataskyddsförordning (2018), GDPR. Läs mer om hur det funkar här.
Så här hanterar KB dina uppgifter vid användning av denna tjänst.

 
pil uppåt Close

Copy and save the link in order to return to this view